Access to this symposium requires KEY ZONE access (paid
registration) to HDCN. For information about subscribing to HDCN,
please go to this link. |
|
Renal
Replacement Therapy in Hepatorenal Failure
|
|
Safirstein R.
|
State-of-the-Art:
Pathophysiology of HRF |
|
|
|
Davenport A.
|
Continuous Renal
Replacement Therapy in HRF |
|
|
|
Fischer K.
|
Anticoagulation in HRF |
|
|
|
Mullen K.
|
Application of
Molecular Absorbent Recirculating System (MARS) in HRF |
|
|
|
Cardiovascular
Disease in Peritoneal Dialysis and Hemodialysis
|
|
Agarwal K.
|
Predictive Value
of Troponins, Thallium Scanning, Dobutamine Stress Echo and Electron
Beam CT Studies in Dialysis Patients Compared to the General Population |
|
|
|
Collins A.
|
Role of Conventional
Risk Factors: USRDS Data |
|
|
|
Burkart J.
|
Hypertension in PD: The Importance
of Ultrafiltration with Long Dwells |
|
|
|
Lindholm B.
|
Systemic Inflammation
and Cardiovascular Disease in HD and PD Patients |
|
|
|
Prichard S.
|
Advances in Understanding the Pathogenesis
of Arteriosclerosis in Uremia |
|
|
|
|
